Yeo C J
Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-4606, USA.
Surg Oncol Clin N Am. 1998 Jan;7(1):143-56.
In patients with resectable adenocarcinoma of the head of the pancreas, pancreaticoduodenectomy serves as the cancer-directed operation of choice. The pylorus-preserving modification of pancreaticoduodenectomy is commonly performed in this setting. Reconstruction of the gastrointestinal tract following pylorus-preserving pancreaticoduodenectomy can be accomplished using various techniques. The operative mortality rate in experienced hands is generally less than 3%, with a postoperative complication rate in the range of 35% to 40%. Patient survival following resection is largely determined by tumor biology, based on such parameters as tumor diameter, lymph node status, resection margin status, and DNA content, and is not adversely influenced by pylorus-preserving pancreaticoduodenectomy.
对于可切除的胰头腺癌患者,胰十二指肠切除术是首选的针对癌症的手术。在这种情况下,通常会进行保留幽门的胰十二指肠切除术改良术式。保留幽门的胰十二指肠切除术后的胃肠道重建可采用多种技术完成。在经验丰富的医生手中,手术死亡率一般低于3%,术后并发症发生率在35%至40%之间。切除术后患者的生存情况很大程度上由肿瘤生物学特性决定,这些特性包括肿瘤直径、淋巴结状态、切缘状态和DNA含量等参数,并且不受保留幽门的胰十二指肠切除术的不利影响。